Imago BioSciences Funding: $1.4B Raised, Series C (2020)
Imago BioSciences has raised $1.4B in total funding. Latest round: Series C. Backed by Merck.
Imago BioSciences funding overview
Imago BioSciences has raised $1.4B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series C announced in November 2020. The round record for Imago BioSciences runs through 2020; nothing later has been disclosed. Investors on record include Merck.
Imago BioSciences at a glance
Total raised
$1.4B
Latest round
Series C
Latest round date
November 2020
Notable investors
Merck
Frequently asked about Imago BioSciences funding
How much has Imago BioSciences raised?
Imago BioSciences has raised $1.4B in total disclosed funding across the rounds on record.
Who has invested in Imago BioSciences?
Merck are named among the investors backing Imago BioSciences.
What was the latest Imago BioSciences funding round?
The most recent disclosed round is a Series C, announced in November 2020.
Where is Imago BioSciences based?
No headquarters location is disclosed for Imago BioSciences.
When did Imago BioSciences last raise?
The last disclosed Imago BioSciences round closed in November 2020 at Series C.
We update the Imago BioSciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.
